# Vitamin D 24'000 IU for Oral Intermittent Supplementation

> **NCT03920150** · PHASE3 · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 58 (actual)

## Conditions studied

- Vitamin D Deficiency

## Interventions

- **DRUG:** Vitamin D3
- **DRUG:** Vitamin D oily capsules
- **DRUG:** Vitamin D oily capsules

## Key facts

- **NCT ID:** NCT03920150
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-30
- **Primary completion:** 2020-05-31
- **Final completion:** 2020-05-31
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2020-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03920150

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03920150, "Vitamin D 24'000 IU for Oral Intermittent Supplementation". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03920150. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*